Get started
Author

Christopher J. Byrne

Observed names: Byrne, Christopher, Byrne, Christopher J., C Byrne, C. Byrne, C. J. BYRNE, C.J. Byrne, Chris J Byrne, Christopher Byrne, Christopher J Byrne
Observed institutions: National Health Service, Sydney South West Area Health Service, The University of Sydney, University of Dundee, Royal Prince Alfred Hospital, NHS Tayside, Ninewells Hospital, King's Cross Hospital, The University of Adelaide
ORCID: 0000-0002-7586-7712
Observed ORCID: 0000-0002-7586-7712
OpenAlex ID: A5058364532
Meta-analysis of well-designed nonrandomized comparative studies of surgical procedures is as good as randomized controlled trials
2009 · Ned S. Abraham, Christopher J. Byrne, et al. · Journal of Clinical Epidemiology · 209
A global research priority agenda to advance public health responses to fatty liver disease
2023 · Jeffrey V. Lazarus, Henry E. Mark, et al. · Journal of Hepatology · 136
PDF
The Structure of the Active Material in Hematoporphyrin Derivative
1987 · C.J. Byrne, L.V. Marshallsay, et al. · Photochemistry and Photobiology · 46
A Global Systematic Review of Hepatitis C Elimination Efforts through Micro-Elimination
2022 · Jeffrey V. Lazarus, Camila A. Picchio, et al. · Seminars in Liver Disease · 43
PDF
Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis
2024 · Marc Gurun, Paul Brennan, et al. · PLoS ONE · 35
A narrative review of lifestyle management guidelines for metabolic dysfunction–associated steatotic liver disease
2024 · Dana Ivancovsky Wajcman, Christopher J. Byrne, et al. · Hepatology · 33
Real‐world outcomes of rapid regional hepatitis C virus treatment scale‐up among people who inject drugs in Tayside, Scotland
2021 · Christopher J. Byrne, Lewis Beer, et al. · Alimentary Pharmacology & Therapeutics · 25
PDF
Psychosocial factors associated with overdose subsequent to Illicit Drug use: a systematic review and narrative synthesis
2024 · Christopher J. Byrne, Fabio Sani, et al. · Harm Reduction Journal · 19
PDF
Viral hepatitis testing and treatment in community pharmacies: a systematic review and meta-analysis
2024 · Mark J. Hayes, Emma Beavon, et al. · EClinicalMedicine · 17
Reaching people receiving opioid agonist therapy at community pharmacies with hepatitis C virus: an international randomised controlled trial
2022 · Christopher J. Byrne, Andrew Radley, et al. · Alimentary Pharmacology & Therapeutics · 16
PDF
The identification of a carbon linked oligomer in hematoporphyrin derivative and photofrin II
1989 · Christopher J. Byrne, A. David Ward · Tetrahedron Letters · 16
Optimal ALT threshold for the automated diagnosis of MASLD: A population-based study using iLFT
2024 · Jeremy Lee, Christopher J. Byrne, et al. · Annals of Hepatology · 15
The electronic effect of the phenylazo and t-butylazo groups
1987 · Christopher J. Byrne, Duncan A. R. Happer, et al. · Journal of the Chemical Society Perkin Transactions 2 · 15
Toward microelimination of hepatitis C and HIV coinfection in NHS Tayside, Scotland: Real‐world outcomes
2020 · Christopher Byrne, Emma Robinson, et al. · Health Science Reports · 14
PDF
Reaching mEthadone users Attending Community pHarmacies with HCV: an international cluster randomised controlled trial protocol (REACH HCV)
2020 · Christopher Byrne, Andrew Radley, et al. · BMJ Open · 13
PDF
A facile porphyrin esterification / etherification procedure
1988 · Christopher J. Byrne, A.David Ward · Tetrahedron Letters · 13
Laying the foundations for hepatitis C elimination: evaluating the development and contribution of community care pathways to diagnostic efforts
2023 · Emma Robinson, Christopher J. Byrne, et al. · BMC Public Health · 10
PDF
Randomized clinical trial: Direct‐acting antivirals as treatment for hepatitis C in people who inject drugs: Delivered in needle and syringe programs via directly observed therapy versus fortnightly collection
2022 · Lewis Beer, Sarah Inglis, et al. · Journal of Viral Hepatitis · 10
PDF
Randomised controlled trial conducted in injecting equipment provision sites to compare the effectiveness of different hepatitis C treatment regimens in people who inject drugs: A Direct obserVed therApy versus fortNightly CollEction study for HCV treatment—ADVANCE HCV protocol study
2019 · Sarah K Inglis, Lewis JZ Beer, et al. · BMJ Open · 10
PDF
The Photodynamic Therapy (PDT) Anticancer Activity of a Range of Porphyrin Dimers and Related Compounds Derived from Hematoporphyrin
2004 · Christopher J. Byrne, Mathew A. Cooper, et al. · Australian Journal of Chemistry · 8
Long-term risk factors for developing Barrett’s oesophagus in patients with gastro-oesophageal reflux disease: a longitudinal cohort study
2024 · Christopher J Byrne, Paul Brennan, et al. · BMJ Open Gastroenterology · 7
PDF
Mixed-methods evaluation of point-of-care hepatitis C virus RNA testing in a Scottish prison
2023 · Christopher J Byrne, Amy Malaguti, et al. · BMJ Open · 6
PDF
Drug network identification predicts injecting risk behavior among people who inject drugs on hepatitis C virus treatment in Tayside, Scotland
2022 · Amy Malaguti, Christopher J. Byrne, et al. · Behavioral Medicine · 4
‘It was like coming back from the clouds’: a qualitative analysis of the lived experience of overdose consequent to drug use among a cohort of people who use drugs in Scotland
2024 · Christopher J. Byrne, Fabio Sani, et al. · Harm Reduction Journal · 3
A multicomponent holistic care pathway for people who use drugs in Tayside, Scotland
2023 · Christopher J Byrne, Andrew Radley, et al. · International Journal of Drug Policy · 3
Works count: 46
Citation count: 734
H-index: 14
I10-index: 19
Year
Topic
Type